Medically Speaking: GERD

Published Online: Friday, July 20, 2012
Follow Pharmacy_Times:
In this podcast interview, Bruce Greenwald, MD, a gastroenterologist at the University of Maryland Medical Center, offers an introduction to gastroesophageal reflux disease (GERD) addressing the following topics: disease overview; symptoms; risk factors; treatment by behavioral management and medication; possible complications; endoscopy as a diagnostic procedure; and when to consult a physician about GERD.
 
To listen to the podcast, click here.
Related Articles
The FDA today approved Ivax Pharmaceuticals’ esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca’s proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year.
Patients on 20-mg maintenance doses of esomeprazole reported no more than mild symptom severity.
As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications.
As nearly one-third of patients with gastroesophageal reflux disease are partial responders to proton pump inhibitors (PPIs), health care professionals could benefit from reliable methods that predict who will respond to PPIs and who will not.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$